Scarica l'app Stockscreener
1.5722
0.95%
-0.0128
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMRA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.585
Aprire:
$1.575
Volume 24 ore:
1,005
Relative Volume:
0.09
Capitalizzazione di mercato:
$4.88M
Reddito:
$4.33M
Utile/perdita netta:
$-4.17M
Rapporto P/E:
-1.0514
EPS:
-1.4953
Flusso di cassa netto:
$-3.19M
1 W Prestazione:
-0.63%
1M Prestazione:
-4.38%
6M Prestazione:
-27.65%
1 anno Prestazione:
-53.96%
Intervallo 1D:
$1.575
$1.579
Intervallo di 1 settimana:
$1.50
$1.65
Portata 52W:
$1.45
$3.60
Biomerica Inc Stock (BMRA) Company Profile
Nome
Biomerica Inc
Settore
Industria
Telefono
(949) 379-2875
Indirizzo
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
1.579 | 4.70M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
115.49 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
329.36 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.48 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.81 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.97 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-11-10 | Iniziato | Colliers Securities | Buy |
| 2018-01-04 | Iniziato | B. Riley FBR, Inc. | Buy |
Biomerica Inc Borsa (BMRA) Ultime notizie
BMRA Q2 2026 Earnings: EPS Loss of $0.44 Highlights Cost-Heavy Development PhaseEarnings Season Review - Vinanet
Biomerica (BMRA) Slips 2.47% to $1.58 as Shares Test Key Support ZonePassive Flow - dars.gov.et
Biomerica (BMRA) Advances 3.18% to $1.62, Pressing Against Key Resistance at $1.70Volume Rate Change - Vinanet
Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biomerica (BMRA) Edges Lower to $1.5: Navigating Support and ResistanceStock Picks - Vinanet
BMRA Q2 2026 Earnings: Loss of $0.44 Per Share Amid Thin DisclosureBook Value Growth - Vinanet
Biomerica Inc (BMRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomerica (BMRA) Q2 2026 Earnings: Net Loss Per Share of -$0.44 Highlights Challenging QuarterNet Profit Margin - dars.gov.et
BMRA|Biomerica Inc|Price:1.620|Chg%:+0.035 - TradingKey
Biomerica Inc (BMRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biomerica Inc (BMRA) Income Statement - tradingkey.com
Biomerica Inc (BMRA) Institutional Confidence - TradingKey
Biomerica Inc (BMRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
BMRA|Biomerica Inc|Price:1.540|Chg%:-0.080 - TradingKey
Biomerica Inc (BMRA) Balance Sheet - TradingKey
Biomerica (BMRA) Holds Near Support After Minor DeclineDealer Gamma - Vinanet
BMRA|Biomerica Inc|Price:1.585|Chg%:+0.015 - TradingKey
Biomerica, Inc. Revenue Breakdown – NASDAQ:BMRA - TradingView
Biomerica Inc. (BMRA) Edges Higher in Quiet TradingHedge Fund Favorites - dars.gov.et
Biomerica Inc. (BMRA) Edges Higher in Low-Volume Trading, Testing Key Resistance ZoneMAMA Signal - dars.gov.et
BMRA Q2 2026 Earnings: EPS Misses as Revenue Data Unavailable, Stock Rebounds SlightlyEarnings Deceleration Risk - Vinanet
BMRA Q2 2026 Earnings: Reported Loss of -$0.44 per Share; Stock Gains $1.52Analyst Consensus Shift - Vinanet
BMRA Q2 2026 Earnings: Net Loss of $0.44 per Share; Stock Declines 3.55%Analyst Consensus Shift - Vinanet
BMRABiomerica Inc Short Interest - Finviz
Biomerica Inc. (BMRA) Q2 2026 Earnings: Negative EPS as Company Continues Operational FocusQuarterly Earnings Report - dars.gov.et
BMRA Q2 2026 Earnings: Diagnostics Firm Posts Wider-Than-Expected Loss as Stock RisesProfitability Analysis - dars.gov.et
Price to sales forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Enterprise value to EBITDA forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Price to earnings forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Biomerica Inc. (BMRA) Edges Higher as Stock Tests Key Resistance LevelWyckoff Accumulation - dars.gov.et
Biomerica Inc (BMRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biomerica Inc (BMRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biomerica | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
BMRA Q1 2026 Earnings: Net Loss Reported Amid Operational ChallengesFree Cash Flow Trends - dars.gov.et
Biomerica Inc (BMRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomerica Inc (BMRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomerica (BMRA) Slips Slightly to $2.05; Near Key Support Amid Quiet TradingDark Pool Volume - newsline.com
Biomerica (BMRA) Edges Lower, Testing Key Support at $1.95ETF Liquidity - newsline.com
Biomerica (BMRA) Edges Higher as Stock Holds Above Key Support LevelIV Contraction - newsline.com
BMRA Q1 2026 Earnings: Net Loss of $0.44 per Share; Stock Declines 0.92%Analyst Consensus Shift - newsline.com
Biomerica (BMRA) Slides Slightly as Stock Approaches Key Support LevelIceberg Order - newsline.com
Biomerica (BMRA) Q1 2026 Earnings: Narrowing Loss Amid Ongoing Operational ChallengesReturn On Capital - newsline.com
Biomerica, Inc. Announces $500,000 Securities Purchase Agreement and Secured Promissory Note – Form 8-K Filing, May 29, 2026 – Minichart - Minichart
Biomerica Enters Related-Party Deal to Boost Liquidity - TipRanks
Biomerica to Sell 6% Diagnosis Stake for $500,000; Issues 8% Note Pending Transfer - TradingView
Biomerica (BMRA) sells 6% Diagnosis S.A. stake to CEO-affiliated buyers - Stock Titan
Biomerica Inc. (BMRA) Sees Modest Gain as Shares Test Key ResistanceDip Buy Trade - newsline.com
BMRA Q1 2026 Earnings: Operating Loss Widens to $0.44 per Share as Pre-Revenue Biotech Advances Pipeline - newsline.com
Biomerica secures USD 1.75M contract for IVD diagnostic development - Medical Buyer
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
Biomerica Inc. Awarded $1.75 Million Contract for IVD Product Development - geneonline.com
Biomerica Inc Azioni (BMRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):